Australia markets closed

Entheon Biomedical Corp. (ENTBF)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.0421-0.0001 (-0.24%)
At close: 12:08PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 486.80k
Enterprise value 267.63k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.39
Price/book (mrq)1.73
Enterprise value/revenue 4.88
Enterprise value/EBITDA -0.31

Trading information

Stock price history

Beta (5Y monthly) 1.57
52-week change 3110.00%
S&P500 52-week change 323.63%
52-week high 30.2000
52-week low 30.0040
50-day moving average 30.1117
200-day moving average 30.0547

Share statistics

Avg vol (3-month) 31.16k
Avg vol (10-day) 3170
Shares outstanding 58.86M
Implied shares outstanding 611.11M
Float 87.66M
% held by insiders 12.14%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 312 Nov 2020
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 30 Nov 2023
Most-recent quarter (mrq)31 May 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-48.64%
Return on equity (ttm)-86.71%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-337.8k
Diluted EPS (ttm)-0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)299.14k
Total cash per share (mrq)0.03
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)7.95
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-351.32k
Levered free cash flow (ttm)-238.74k